Steven J. Mento, President, CEO & Director at Conatus Pharmaceuticals Inc (CNAT), bought 110,518 shares at $11.00 ($167K) on 2013-07-30, disclosed to the SEC on 2013-08-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 95,323 | $0 | 0.0% |
| 2 | $11.00 | 1,395 | $15K | 9.2% |
| 3 | $11.00 | 13,800 | $152K | 90.8% |
| Total | $1.51 avg | 110,518 | $167K | 100% |
| Filing → |
| SGMO | SELL | 2018-02-05 | $474K | — | Filing → |
| SGMO | SELL | 2015-03-06 | $119K | — | Filing → |
| SGMO | SELL | 2014-12-15 | $95K | — | Filing → |